Fluid loading of 500 mL of crystalloid solution
OtherInfusion of 500 mL of crystalloid solution in less than 15 minutes
NCT Number: NCT03225378
The passive leg raising (PLR) test is a reversible preload challenge of around 300 mL of blood that can be repeated as frequently as required without infusing a drop of fluid. Two recent meta-analyses of many studies have confirmed the reliability of the PLR test to predict fluid responsiveness in patients with acute circulatory failure. Nevertheless, the effects of the PLR must be assessed by the direct measurement of cardiac output since changes in arterial pressure do not allow the assessment of the PLR hemodynamic effects with reliability. Moreover, cardiac output must be measured continuously and in real time.
In clinical practice, cardiac output measurement can be difficult for different reasons such as the unavailability of the echocardiography machine, or the absence of any continuous cardiac output monitoring technique at the time of acute circulatory failure occurrence.
Recently, it was shown that the decrease in pulse pressure variation (PPV) induced by the mini-fluid challenge (100 mL of colloid solution infused in 1 min) was able to predict fluid responsiveness with reliability in patients ventilated with low tidal volume (<8 mL/kg of ideal body weight).
Therefore, the investigators hypothesize that the changes in PPV induced by PLR test could be able to predict fluid responsiveness with reliability in mechanically ventilated patients with acute circulatory failure.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
CHU d'Amiens - Réanimation Cardio-Thoracique-Vasculaire, Amiens, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(1) systolic arterial pressure <90 mmHg, mean arterial pressure <65 mmHg, or the need for vasopressor infusion; (2) skin mottling; (3) urine output <0.5 mL/Kg/h for more than or equal to 2 hours; (4) lactate concentrations > 2 mmol/L
Non inclusion Criteria:
Exclusion criteria
Infusion of 500 mL of crystalloid solution in less than 15 minutes
This intervention is done before the fluid loading in order to predict fluid responsiveness.
Time frame: Cardiac output will be measured immediately after the end of the volume expansion
The primary endpoint is the increase in cardiac output of more than or equal to 15% after 500 mL of volume expansion. All included patients are concerned by the primary outcome.
Time frame: Cardiac output will be measured immediately after the end of the volume expansion
The secondary endpoint is the increase in cardiac output of more than or equal to 15% after 500 mL of volume expansion. Only patients with spontaneous breathing activities are concerned by this secondary outcome.
Time frame: Cardiac output will be measured immediately after the end of the volume expansion
The secondary endpoint is the increase in cardiac output of more than or equal to 15% after 500 mL of volume expansion. Only patients with low tidal ventilation (<8mL/kg of ideal body weight) and/or low respiratory compliance (<30mL/cmH2O) are concerned by this secondary outcome.
Centre Hospitalier Arras
Other
Changes in Pulse Pressure Variations Induced by Passive Leg Raising Test to Predict Fluid Responsiveness in ICU
Acronym: VPP-ImPRoVE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02050269
Acute Circulatory Failure, Pathologic Processes
Orléans, France
View Trial DetailsNCT03680963
Acute Circulatory Failure, Pathologic Processes
Argenteuil, France
View Trial DetailsNCT04360304
Acute Circulatory Failure, Pathologic Processes
Nîmes, Gard, France
View Trial DetailsNCT03788772
Acute Circulatory Failure, Infections
Paris, France
View Trial Details